Oramed Pharmaceuticals (NASDAQ:ORMP) Posts Earnings Results, Misses Expectations By $0.01 EPS
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01).
Source link